Azalea Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 30-06-2024
- Paid Up Capital ₹ 5.00 M
as on 30-06-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 30-06-2024
- Revenue -97.29%
(FY 2022)
- Profit 116.82%
(FY 2022)
- Ebitda 117.20%
(FY 2022)
- Net Worth 44.78%
(FY 2022)
- Total Assets -68.35%
(FY 2022)
About Azalea Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹1.00 Cr.
Hiteshkumar Chauhan and Malay Mehta serve as directors at the Company.
- CIN/LLPIN
U51909GJ2017PTC097257
- Company No.
097257
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 May 2017
- Date of AGM
03 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Azalea Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hiteshkumar Chauhan  | Director | 10-May-2017 | Current |
| Malay Mehta | Director | 10-May-2017 | Current |
Financial Performance of Azalea Life Sciences.
Azalea Life Sciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 97.29% decrease. The company also saw a substantial improvement in profitability, with a 116.82% increase in profit. The company's net worth Soared by an impressive increase of 44.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Azalea Life Sciences?
In 2021, Azalea Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Aquaren Pharmaceuticals Private LimitedActive 1 year 6 months
Hiteshkumar Chauhan is a mutual person
- Eutrophic Pharmaceuticals Private LimitedActive 2 years 22 days
Hiteshkumar Chauhan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Feb 2019 | ₹5.00 M | Open |
Others Creation Date: 12 Feb 2019 | ₹5.00 M | Open |
How Many Employees Work at Azalea Life Sciences?
Unlock and access historical data on people associated with Azalea Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Azalea Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Azalea Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
